R&D Making a difference for traumatic brain injury patients TBI is the leading cause of death and disability in young adults in the developed world.
R&D The transformation of brain implants Nicolas Vachicouras, CEO of Neurosoft Bioelectronics, tells us how Neurosoft's electrode implant aims to reduce inflammation and scar tissue for patients, provide higher quality brain recor
News FDA fast-tracks NeuroVive's traumatic brain injury drug The FDA has fast-tracked a drug to treat severe traumatic brain injury from Swedish pharma NeuroVive, hastening its development and review.
News Vasopharm drug could limit damage caused by brain injuries German biotech moves into phase 3 after a long wait
News World first as infant gets personalised CRISPR therapy In a medical breakthrough, a child diagnosed with a rare genetic disorder has received a bespoke CRISPR gene editing therapy to correct the mutation.
Market Access Sponsored Bridging research and clinical guidelines – interactive stra... Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.
